ClinicalTrials.gg
Drug

Medroxyprogesterone Acetate clinical trials

Also written DMPA, Provera, Depo-Provera and TV-46046.

A product of Medroxyprogesterone; its studies count on that page too.

studies test it
74
open now
8
in phase 3
19
first study started
1996

How each study uses Medroxyprogesterone Acetate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Medroxyprogesterone Acetate studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
18 Jun 1959 · PROVERA · NDA 011839 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

medroxyprogesterone acetate
11
Depo Provera
9
Depot medroxyprogesterone acetate
6
Sayana Press
5
MPA
4

Brand

Provera
8
Depo-Provera
4
depo-subQ provera 104™
2
Cycrin
1
Provera 10 mg
1

Development codes

TV-46046
2

Other names

DMPA
14
Medroxyprogesterone 17-Acetate
4

Studies by the year they started

73 studies that test it; most in 2015 (9); 1 more planned to start later

Studies that test Medroxyprogesterone Acetate, by start year
YearStudies
19961
19991
20001
20011
20021
20031
20042
20051
20061
20073
20082
20093
20104
20113
20122
20131
20144
20159
20161
20175
20183
20193
20202
20213
20223
20236
20241
20254
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
4
Phase 1
8
Phase 2
16
Phase 3
19
Phase 4
24
No phase
10

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 9 · Other 65

FHI 360 (5) · Teva Branded Pharmaceutical Products R&D, Inc. (3) · Pfizer (2) · University of Washington (2) · Assiut University (2) · Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (2) · Botswana Harvard AIDS Institute Partnership (1) · Northwestern University (1)

Often tested with

Tested in the same studies.

Levonorgestrel (3) · Conjugated estrogens (3) · Contraceptives, Oral, Combined (2) · Dydrogesterone (2) · Estradiol (2) · Megestrol Acetate (2) · Megestrol (2) · Letrozole (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test Medroxyprogesterone Acetate.

Studies

Open first, then newest update. How each study uses Medroxyprogesterone Acetate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 74

See all 74 studies that test Medroxyprogesterone Acetate →

Given beside what is tested · 10 — Medroxyprogesterone Acetate is usual care or a partner of the new treatment
As the comparator · 14 — what is tested is compared with Medroxyprogesterone Acetate

Codes

What other systems call Medroxyprogesterone Acetate · ClinicalTrials.gg INT008565

  • MeSH (NLM) D017258Medroxyprogesterone AcetateConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) C2QI4IOI2GMEDROXYPROGESTERONE ACETATEConfirmed FDA, NLM, Wikidata
  • RxNorm 1000112Confirmed FDA, Wikidata
  • Wikidata Q2823834medroxyprogesterone acetateConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1155Medroxyprogesterone AcetateOne source FDA
  • DrugBank DB00603One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.